Approval · Notice of Compliance 31176 · 2023
PLERIXAFOR INJECTION: Notice of Compliance 31176
Issued July 11, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31176
- Date
- July 11, 2023
- Company
- Eugia Pharma Inc.Woodbridge, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- MOZOBIL (Sanofi-Aventis Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PLERIXAFOR INJECTION | 02539454 | Marketed |
Medicinal ingredients
- PLERIXAFOR 24 MG per 1.2ML